Helmut Zodl - Mar 1, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role: Chief Financial Officer
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol: GEHC
Transactions as of: Mar 1, 2023
Transactions value $: -$133,883
Form type: 4
Date filed: 3/3/2023, 06:53 PM
Previous filing: Dec 29, 2023
Next filing: Apr 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GEHC	Common Stock, par value $0.01 per share	Award	$0	+9.96K	+20.63%	$0.00	58.2K	Mar 1, 2023	Direct	F1, F2
transaction	GEHC	Common Stock, par value $0.01 per share	Tax liability	-$134K	-1.78K	-3.05%	$75.30	56.5K	Mar 1, 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GEHC	Employee Stock Option (right to buy)	Award	$0	+27.8K		$0.00	27.8K	Mar 1, 2023	Common Stock, par value $0.01 per share	27.8K	$75.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.
F2	Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3	Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F4	Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.